| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |